APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 263 filers reported holding APELLIS PHARMACEUTICALS INC in Q2 2024. The put-call ratio across all filers is 0.13 and the average weighting 0.2%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Octagon Capital Advisors LP | 2,880,880 | $110,510,557 | 17.37% |
| EcoR1 Capital, LLC | 11,607,425 | $445,260,823 | 13.62% |
| Logos Global Management LP | 2,000,000 | $76,720,000 | 6.23% |
| Avoro Capital Advisors LLC | 11,111,111 | $426,222,218 | 5.68% |
| Boxer Capital, LLC | 1,726,000 | $66,209,360 | 3.49% |
| Deep Track Capital, LP | 2,500,000 | $95,900,000 | 2.86% |
| Octagon Capital Advisors LP | 350,000 | $13,426,000 | 2.11% |
| Ghost Tree Capital, LLC | 135,000 | $5,178,600 | 1.62% |
| Exome Asset Management LLC | 46,900 | $1,799,084 | 1.57% |
| Artal Group S.A. | 1,467,080 | $56,277,189 | 1.44% |
| Logos Global Management LP | 400,000 | $15,344,000 | 1.25% |
| Orbimed Advisors | 1,302,800 | $49,975,408 | 0.99% |
| Vestal Point Capital, LP | 335,000 | $12,850,600 | 0.96% |
| BRAIDWELL LP | 611,800 | $23,468,648 | 0.74% |
| Sippican Capital Advisors | 23,178 | $889,108 | 0.70% |
| Caption Management, LLC | 1,004,700 | $38,540,292 | 0.59% |
| 683 Capital Management, LLC | 200,000 | $7,672,000 | 0.58% |
| 683 Capital Management, LLC | 186,000 | $7,134,960 | 0.54% |
| Birchview Capital, LP | 14,000 | $537,040 | 0.50% |
| PDT Partners, LLC | 92,856 | $3,561,956 | 0.34% |
External links
This page lists APELLIS PHARMACEUTICALS INC's shareholders in Q2 2024. To view APELLIS PHARMACEUTICALS INC's shareholder history, click here.